TLSI- Trisalus Life Sciences, Inc.
Trisalus Life Sciences, Inc. (TLSI) has 5 insiders with recent SEC Form 4 filings, including 9 buys and 4 sells. TLSI is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 323.8K | $1.36M | - | |
| CFO | 265.0K | $1.11M | - | |
| Other | 166.6K | $699.7K | - | |
| Other | 113.9K | $478.2K | - | |
| Other | 100.6K | $422.4K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | Cox Bryan F. | Chief Of Research | Sell | 4,764 | $5.18 | $24,677.52 | -3.8% | -6.2% | -39.2% | |
| May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | Sell | 8,704 | $5.18 | $45,086.72 | -10.1% | -6.2% | -39.2% | |
| May 19, 2025 | Devlin Jodi | Chief Of Clinical Operations | Sell | 4,764 | $5.18 | $24,677.52 | -8.3% | -6.2% | -39.2% | |
| May 19, 2025 | Marshak Richard | Chief Commercial Officer | Sell | 6,597 | $5.18 | $34,172.46 | -8.7% | -6.2% | -39.2% | |
| Feb 5, 2025 | Young James Emmett | Chief Financial Officer | Buy | 6,000 | $5.65 | $33,900.00 | +25.0% | -3.6% | -12.2% | |
| Jan 30, 2025 | Szela Mary T47 | CEO And President | Buy | 10,040 | $5.15 | $51,753.70 | +1.1% | +0.4% | -2.7% | |
| Jan 28, 2025 | Murphy Sean | Chief Manuf, Strategy&Bus Dev. | Buy | 30,000 | $5.24 | $157,200.00 | +8.6% | +15.1% | -0.4% | |
| Jan 28, 2025 | Szela Mary T47 | CEO And President | Buy | 9,542 | $5.27 | $50,302.84 | +1.1% | +15.1% | -0.4% | |
| Jan 27, 2025 | Young James Emmett | Chief Financial Officer | Buy | 24,000 | $5.40 | $129,600.00 | New | +7.9% | -1.5% | |
| Dec 17, 2024 | Frankenius Equity Ab | 10% Owner | Buy | 62,972 | $3.97 | $249,998.84 | +1.0% | +35.2% | +91.6% |
Page 1Next →